HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 22 February 2018

Congratulations to HEDS students on completing their PhDs

Two of our students have successfully completed their PhDs.

Koonal Kirit Shah: "Valuing health at the end of life"

Armando Vargas Palacios: "An Economic Evaluation of the A(H1N1) Flu Vaccine in Mexico"


Wednesday, 21 February 2018

New project: NICE topics

ScHARR-TAG has been allocated the following STA topics:

·         Moxetumomab pasudotox for hairy-cell leukaemia [ID1142]

·         Pembrolizumab for untreated gastric or gastro-oesophageal junction cancer [ID1305]

·         Clostridium botulinum neurotoxin type A for treating hypersalivation associated with neurological conditions [ID1150

Tuesday, 20 February 2018

January’s CEAs.....

Our quick search for CEA’s published in January uncovered 44 articles.   In the right-hand column of this blog is a CEA Archive, which includes our CEA search results by month.  Below are those in our areas of interest.
  • Anderson D, Villagra V, Coman EN, Zlateva I, Hutchinson A, Villagra J, et al. A cost-effectiveness analysis of cardiology eConsults for Medicaid patients. The American journal of managed care. 2018;24(1):e9-e16.
  • Clarke M, Fursse J, Brown-Connolly NE, Sharma U, Jones R. Evaluation of the National Health Service (NHS) Direct Pilot Telehealth Program: Cost-Effectiveness Analysis. Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 2018;24(1):67-76.
  • DiazOrdaz K, Franchini AJ, Grieve R. Methods for estimating complier average causal effects for cost-effectiveness analysis. Journal of the Royal Statistical Society Series A, (Statistics in Society). 2018;181(1):277-97.
  • Itoga NK, Minami HR, Chelvakumar M, Pearson K, Mell MM, Bendavid E, et al. Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test. Vascular medicine (London, England). 2018:1358863x17745371.
  • Pattamatta M, Smeets BJJ, Evers S, Rutten HJT, Luyer MDP, Hiligsmann M. Health-related quality of life and cost-effectiveness analysis of gum chewing in patients undergoing colorectal surgery: results of a randomized controlled trial. Acta chirurgica Belgica. 2018:1-8.
  • Tuffaha HW, Mitchell A, Ward RL, Connelly L, Butler JRG, Norris S, et al. Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers. Genetics in medicine : official journal of the American College of Medical Genetics. 2018.

Monday, 19 February 2018

Canadian Precision Medicine Policy Network Meeting

Professor Simon Dixon was invited to speak at the Policy Network in Banff.  The meeting included academic, industry and licensing experts from across Canada and invited academics from the UK.  The meeting was led by Professor Chris McCabe as part of the PACEOMICS research programme.

Image of Professor Dixon at the Policy Network in Banff
Professor Dixon at the Policy Network in Banff
Simon’s presentation was on UK experience of Value of Implementation Analysis.  The presentation included work undertaken as part of the Department of Health's Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) and work with Dr Sabinne Grimm and Dr John Stevens on diffusion.

Friday, 16 February 2018

January’s CEAs, systematic reviews and epidemiological models in LMICs

To help us keep on top of current research in low and middle-income countries, we are running a monthly search of research that is aligned to our core research interests.  It's a simple search strategy, with those published last month that are most aligned to our interests listed below.  The full list of articles is kept in our "Searches archive" in the right-hand column.
  • Carvalho N, Jit M, Cox S, Yoong J, Hutubessy RCW. Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework. PharmacoEconomics. 2018;36(1):79-90.
  • Dawkins BR, Mirelman AJ, Asaria M, Johansson KA, Cookson RA. Distributional cost-effectiveness analysis in low-and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia. Health policy and planning. 2018.
  • Gomes Casavechia MT, de Melo GAN, Da Silva Fernandes ACB, De Castro KR, Pedroso RB, Da Silva Santos T, et al. Systematic review and meta-analysis on Schistosoma mansoni infection prevalence, and associated risk factors in Brazil. Parasitology. 2018:1-15.
  • Lee TH, Kim W, Shin J, Park EC, Park S, Kim TH. Strategic Distributional Cost-Effectiveness Analysis for Improving National Cancer Screening Uptake in Cervical Cancer: A Focus on Regional Inequality in South Korea. Cancer research and treatment : official journal of Korean Cancer Association. 2018;50(1):212-21.
  • Yaesoubi R, Trotter C, Colijn C, Yaesoubi M, Colombini A, Resch S, et al. The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study. PLoS medicine. 2018;15(1):e1002495.

Wednesday, 14 February 2018

Website of the Month - The Academic Health Economists' Blog

In the second of our new monthly feature, we pick a useful website that readers of this blog will find of interest. This month we have chosen The Academic Health Economists' Blog.  


Image of AHE Blog
https://aheblog.com/
"The Academic Health Economists’ Blog exists to provide an online presence for the discussion of issues and developments in health economics. We provide a place where people can present their views, opinions, ideas, and takes on current affairs from the perspective of health economics. The site has a simple aim; to promote healthy debate in the field, with a sharing of ideas."
Contributions
Get involved! Comment on articles posted on this blog and become a contributor to submit your own posts where appropriate. 

Tuesday, 13 February 2018

New NIHR HTA Reports

HEDS have collaborated on two new published NIHR HTA reports.

Squires, H. et al., 2017. A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults. Health Technology Assessment, 21(68), pp.1–170. Available at: https://www.journalslibrary.nihr.ac.uk/hta/hta21680#/abstract

Image of an open book
CC BY 2.0 Daniel Wehner http://bit.ly/2E8GcmQ
Wailoo, A. et al., 2017. The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis. Health Technology Assessment, 21(71), pp.1–258. Available at: https://www.journalslibrary.nihr.ac.uk/hta/hta21710#/abstract 


January’s CEAs, systematic reviews and epidemiological models in LMICs

To help us keep on top of current research in low and middle-income countries, we are running a monthly search of research that is aligned to our core research interests.  It's a simple search strategy, with those published last month that are most aligned to our interests listed below.  The full list of articles is kept in our "Searches archive" in the right-hand column.
  • Carvalho N, Jit M, Cox S, Yoong J, Hutubessy RCW. Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework. PharmacoEconomics. 2018;36(1):79-90.
  • Dawkins BR, Mirelman AJ, Asaria M, Johansson KA, Cookson RA. Distributional cost-effectiveness analysis in low-and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia. Health policy and planning. 2018.
  • Gomes Casavechia MT, de Melo GAN, Da Silva Fernandes ACB, De Castro KR, Pedroso RB, Da Silva Santos T, et al. Systematic review and meta-analysis on Schistosoma mansoni infection prevalence, and associated risk factors in Brazil. Parasitology. 2018:1-15.
  • Lee TH, Kim W, Shin J, Park EC, Park S, Kim TH. Strategic Distributional Cost-Effectiveness Analysis for Improving National Cancer Screening Uptake in Cervical Cancer: A Focus on Regional Inequality in South Korea. Cancer research and treatment : official journal of Korean Cancer Association. 2018;50(1):212-21.
  • Yaesoubi R, Trotter C, Colijn C, Yaesoubi M, Colombini A, Resch S, et al. The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study. PLoS medicine. 2018;15(1):e1002495.

Monday, 12 February 2018

EQ-5D-5L: Smaller steps but a major step change?

Professor John Brazier has written a collaborative editorial alongside Professor Andrew Briggs and Professor Sterling Bryan for Health Economics journal.

Professor Brazier said: "NICE uses a three level version of the EQ-5D to estimate QALYs. The potential adoption of the new five level version by NICE has important implications for resource allocation in the NHS. This editorial looks at the arguments for adopting the new five level version (EQ-5D-5L) over the existing three level version."

You can read the editorial here

http://onlinelibrary.wiley.com/doi/10.1002/hec.3627/full